Corcept Therapeutics
CORT
#2516
Rank
$5.61 B
Marketcap
$53.63
Share price
2.80%
Change (1 day)
65.42%
Change (1 year)

Corcept Therapeutics (CORT) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : $0.14 Billion USD

According to Corcept Therapeutics 's latest financial reports the company's total liabilities are $0.14 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Corcept Therapeutics - Total liabilities on balance sheet (from 2003 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31$0.11 B40.72%
2022-12-31$81.58 M70.15%
2021-12-31$47.95 M-0.92%
2020-12-31$48.39 M17.66%
2019-12-31$41.13 M14.85%
2018-12-31$35.81 M21.11%
2017-12-31$29.56 M8.02%
2016-12-31$27.37 M-18.05%
2015-12-31$33.4 M-12.14%
2014-12-31$38.01 M-9.61%
2013-12-31$42.06 M12.49%
2012-12-31$37.38 M643.91%
2011-12-31$5.02 M30.21%
2010-12-31$3.86 M59.57%
2009-12-31$2.41 M-15.66%
2008-12-31$2.86 M-4.72%
2007-12-31$3.01 M-15.02%
2006-12-31$3.54 M-0.59%
2005-12-31$3.56 M95.34%
2004-12-31$1.82 M-95.78%
2003-12-31$43.25 M-1.1%
2002-12-31$43.73 M2221.39%
2001-12-31$1.88 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
$108.12 B 74,255.32%๐Ÿ‡บ๐Ÿ‡ธ USA
$76.47 B 52,484.89%๐Ÿ‡บ๐Ÿ‡ธ USA
$60.08 B 41,216.31%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$61.28 B 42,043.69%๐Ÿ‡บ๐Ÿ‡ธ USA
$126.91 B 87,175.65%๐Ÿ‡บ๐Ÿ‡ธ USA
$72.97 B 50,079.48%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.68 B 370.58%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.67 B 363.57%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.43 B 888.71%๐Ÿ‡บ๐Ÿ‡ธ USA